Zobrazeno 1 - 10
of 55
pro vyhledávání: '"MDR-TB treatment"'
Autor:
Dennis Lyakurwa, Johnson Lyimo, Christiaan Mulder, Puck T. Pelzer, Inge Koppelaar, Marleen Heus
Publikováno v:
Human Resources for Health, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Introduction Drug-resistant TB (DR-TB) care shifted from centralized to decentralized care in Tanzania in 2015. This study explored whether DR-TB training and mentoring supported healthcare workers’ (HCWs) DR-TB care performance. Methods T
Externí odkaz:
https://doaj.org/article/b732eb5eab594b84b876e695661214d6
Autor:
Ngabonziza, J.-C.S., Habimana, Y.M., Decroo, T., Migambi, P., Dushime, A., Mazarati, J.B., Rigouts, L., Affolabi, D., Ivan, E., Meehan, Conor J., Van Deun, A., Fissette, K., Habiyambere, I., Nyaruhirira, A.U., Turate, I., Semahore, J.M., Ndjeka, N., Muvunyi, C.M., Condo, J.U., Gasana, M., Hasker, E., Torrea, G., de Jong, B.C.
Yes
SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin dr
SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin dr
Externí odkaz:
http://hdl.handle.net/10454/17785
Autor:
Nicholaus Peter Mnyambwa, Issack Lekule, Esther S. Ngadaya, Godfather Kimaro, Pammla Petrucka, Dong-Jin Kim, Johnson Lymo, Rudovick Kazwala, Fausta Mosha, Sayoki G. Mfinanga
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-6 (2018)
Abstract Objective The gap between patients diagnosed with multi-drug resistant tuberculosis (MDR-TB) and enrolment in treatment is one of the major challenges in tuberculosis control programmes. A 4-year (2013–2016) retrospective review of patient
Externí odkaz:
https://doaj.org/article/139980dc96964f55a79189db0b1d0dbe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L Guglielmetti, Maia Kipiani, Petros Isaakidis, SK Brode, Jonathon R. Campbell, Parvaneh Baghaei, Payam Nahid, Rafael Laniado-Laborín, Lorenzo Guglielmetti, Zhiyi Lan, D Falzon, L Barkane, Vicky Chang, Dafne Paiva Rodrigues, D Menzies, R Singla, Denise Rodrigues, Z Lan, Noor Azlinda Ahmad, JR Campbell, R Laniado-Laborín, Jcm Brust, Nafees Ahmad, Christoph Lange, Andrea Benedetti, Dick Menzies, Zarir F Udwadia, P Nahid, Sarah K. Brode, A Benedetti, RR Kempker, P Baghaei, M Kipiani, Liga Kuksa, Rupak Singla, James C.M. Brust, Linda Barkane, Zarir F. Udwadia, Dennis Falzon, L Kuksa, P Isaakidis, Russell R. Kempker, Vwl Chang
Publikováno v:
Lancet Respir Med
The Lancet. Respiratory medicine, vol 8, iss 4
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2020, 8 (4), pp.383-394. ⟨10.1016/S2213-2600(20)30047-3⟩
The Lancet. Respiratory medicine, vol 8, iss 4
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2020, 8 (4), pp.383-394. ⟨10.1016/S2213-2600(20)30047-3⟩
We regret that this article is behind a paywall.
BACKGROUND: Treatment of multidrug-resistant tuberculosis requires long-term therapy with a combination of multiple second-line drugs. These drugs are associated with numerous adverse events that
BACKGROUND: Treatment of multidrug-resistant tuberculosis requires long-term therapy with a combination of multiple second-line drugs. These drugs are associated with numerous adverse events that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07461c3a4c3574948b0fd06e18795e8b
https://doi.org/10.1016/s2213-2600(20)30047-3
https://doi.org/10.1016/s2213-2600(20)30047-3
Autor:
Saurav Basu, Nandini Sharma, Charu Kohli, Neeti Babbar, Ashwani Khanna, Neeta Singla, K K Chopra, Shivani Chandra
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 151, Iss 6, Pp 598-603 (2020)
Indian Journal of Medical Research, Vol 151, Iss 6, Pp 598-603 (2020)
Background & objectives: The increase in the burden of multidrug-resistant tuberculosis (MDR-TB) is a matter of grave concern. The present study was undertaken to describe MDR-TB treatment outcome trends in Delhi and their epidemiological correlates,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b54d296948ef13f4de570aa49fa7fb3
http://europepmc.org/articles/PMC7602924
http://europepmc.org/articles/PMC7602924
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sayoki Mfinanga, Elingarami Sauli, Stephen H. Gillespie, Wilber Sabiiti, Katharina S. Kreppel, Nyanda E. Ntinginya, Scott K. Heysell, Emmanuel A. Mpolya, Kennedy Kwasi Addo, Peter M. Mbelele, Bariki Mtafya, Stellah G. Mpagama, Patrick P. J. Phillips
Publikováno v:
Journal of Clinical Microbiology
Journal of clinical microbiology, vol 59, iss 4
Journal of clinical microbiology, vol 59, iss 4
Rifampin or multidrug-resistant tuberculosis (RR/MDR-TB) treatment has largely transitioned to regimens free of the injectable aminoglycoside component, despite the drug class’ purported bactericidal activity early in treatment. We tested whether M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1364dff60125d673d17b2aa750ada276
https://doi.org/10.1128/jcm.02927-20
https://doi.org/10.1128/jcm.02927-20
Publikováno v:
International Journal of Mycobacteriology, Vol 4, Iss 5, Pp 159-160 (2015)
Aims and objectives: Multidrug resistant tuberculosis (MDR-TB) management is expensive, prolonged and complicated. After starting anti-tuberculous treatment in MDR-TB patients, microbiological response to therapy is monitored by monthly sputum cultur
Externí odkaz:
https://doaj.org/article/bc2c2ff333974f248fa37b57980aeef6